Cytokinetics CYTK Interest Receivable And Amortization On Investments
Interest Receivable And Amortization On Investments at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept cytk:InterestReceivableAndAmortizationOnInvestments.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's interest receivable and amortization on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's interest receivable and amortization on investments?
- Cytokinetics (CYTK) reported interest receivable and amortization on investments of -$1.87M in Q1 2026.
- How has Cytokinetics's interest receivable and amortization on investments changed year-over-year?
- Cytokinetics's interest receivable and amortization on investments increased by 69.6% year-over-year, from -$6.17M to -$1.87M.
- What is the long-term trend for Cytokinetics's interest receivable and amortization on investments?
- Over 4 years (2021 to 2025), Cytokinetics's interest receivable and amortization on investments has grown at a 34.4% compound annual growth rate (CAGR), from $4.89M to -$15.98M.
- What does interest receivable and amortization on investments mean?
- The accounting adjustment for interest earned on investments.
- How do you interpret interest receivable and amortization on investments?
- Higher values indicate better returns on idle cash or investment portfolios.
- How does interest receivable and amortization on investments compare across companies?
- Standard for companies with significant cash balances or marketable securities.